- December 14, 2021
- By: Admin1_blog
- Asia Market, Indices
- U.S. stocks pulled back overnight, with the S&P falling from a record start earlier in the week.
- Caution on the new omicron variant prevailed again. China reported its first omicron case.
- The University of Oxford published results on Monday showing two doses of the Oxford-AstraZeneca or Pfizer-BioNTech Covid-19 vaccines are substantially less effective at warding off omicron compared to previous variants of the coronavirus.
SINGAPORE — Chinese stocks declined on Tuesday, tracking other losses in Asia-Pacific markets, as the omicron variant returned to focus. Meanwhile, bitcoin prices continued to tumble after some losses overnight.
Hong Kong’s Hang Seng index led losses, tumbling 0.91%. Tech stocks dipped, with Alibaba down 1.16%, Tencent losing about 1%. JD tumbled nearly 2%. The Hang Seng tech index was down 1.53%.
Chinese telecommunications operator China Mobile announced in a filing that it has received approval from regulators for a secondary listing in Shanghai, for an offering of up to 845.87 million shares.
Mainland Chinese shares were also in negative territory in early trading. The Shanghai composite was down 0.4%, while the Shenzhen component dipped 0.42%.
Japan’s Nikkei 225 lost 0.35%, while the Topix was up 0.12%.
However, South Korea’s Kospi inched down 0.12%, with tech names in the red. SLG Electronics was down 2.61%.
Australia’s S&P/ASX 200 dipped 0.23%.
Bitcoin prices continued to decline in the morning during Asia trade, after tumbling overnight to a low of over $45,800. It last declined 7% to $46,868, according to Coin Metrics.
Renewed caution on omicron variant
Caution on the new omicron variant prevailed again as the U.K. confirmed Monday that at least one patient infected with the new omicron variant of Covid-19 has died in the country. China also reported its first omicron case, according to Reuters.
The University of Oxford published results on Monday showing two doses of the Oxford-AstraZeneca or Pfizer-BioNTech Covid-19 vaccines are substantially less effective at warding off omicron compared to previous variants of the coronavirus. The study has yet to be peer-reviewed.
The research paper noted that some vaccine recipients “failed to neutralize” the virus at all.
Stock picks and investing trends from CNBC Pro:
Jim O’Neill, Dan Niles, Guy Spier and 7 other market strategists share their best advice for 2022
Stocks head for a rare third-straight year of double-digit returns. What happens next?
Goldman loves these EV sector stocks — and says one could rally 100%
U.S. stocks pulled back overnight, with the S&P falling from a record start earlier in the week. It fell 0.9% to 4,668.97 and sits about 1.6% from its intraday record. The Dow Jones Industrial Average traded 320 points lower to 35,650.95. The technology-focused Nasdaq Composite fell nearly 1.4% to 15,413.28.The technology-focused Nasdaq Composite fell nearly 1.4% to 15,413.28.
“An increasing number of companies in Europe are telling staff to work from home amid rising cases numbers. Further research shows the lower protection from two doses of mRNA vaccines. China also reported its first case of Omicron. This offset a more bullish view of the oil market from OPEC,” ANZ Research analysts Brian Martin and Daniel Hynes wrote in a Tuesday note.
Oil prices fell Monday on renewed doubts about the variant. However, they were little changed in the morning during Asia hours. U.S. crude inched marginally down to $71.23 per barrel, while Brent futures were near the flatline at $74.33.
Investor focus will also likely be on the Fed’s latest two-day policy meeting, which kicks off on Tuesday. After the meeting wraps up on Wednesday, the Fed is expected to announce that it will speed up the pace of tapering its asset purchasing program.
|.N225||Nikkei 225 Index||*NIKKEI||28504.15||-136.34||-0.48|
|.HSI||Hang Seng Index||*HSI||23668.95||-285.63||-1.19|
|.AXJO||S&P/ASX 200||*ASX 200||7376.1||-3.2||-0.04|
|.FTFCNBCA||CNBC 100 ASIA IDX||*CNBC 100||9913.23||-48.93||-0.49|
The U.S. dollar index, which tracks the greenback against a basket of its peers, was at 96.416 — sharply rising from levels around 96.3 earlier.
The Japanese yen traded at 113.62 per dollar, weakening from around 113.2 in earlier sessions. The Australian dollar was at $0.7112, falling back from earlier levels of around $0.713.
Source : CNBC
Leave a Reply